|
Market Cap (19-May) $4,758,880 (1,313th) |
Close (30-Jun) $1.51 |
Volume (30-Jun) 12,937 |
Shortsold (8-Aug) 2,108 (0.02%) (508th) |
|
52w High $1.09 |
52w Low $0.280 |
P/E - |
EPS -0.42 |
ZLD released this announcement to the ASX on 22 February 2023, 13:08. The announcement is not marked as price sensitive, and is 15 page(s) in length and 15.04MB in size.
You can view all announcements from ZLD and see how they appear on a price chart on the announcements page.
At the date of this announcement, ZLD was 0.031% short sold according to ASIC data. It was ranked the 485th most shorted stock on the ASX. It remains ranked 508th as of the latest reported data (08 August 2024).
| Other Recent Announcements from ZLD | |
|---|---|
| Amendment to ASX announcement - Zelira's diabetic nerve pai | 8 June 2023, 9:47 |
| Initial Director's Interest Notice | 1 June 2023, 15:29 |
| Final Director's Interest Notice | 1 June 2023, 15:27 |
| Zelira HOPE 1 SPV Investor Presentation | 22 February 2023, 13:08 |
| Initial Director's Interest Notice | 21 February 2023, 20:12 |
| Zelira HOPE 1 SPV Investor Briefing Webinar | 21 February 2023, 9:37 |
| Zelira Executive Director Appointed | 20 February 2023, 12:37 |
You must be logged in to post a reply.
Zelira Therapeutics 